Shpro (Mixture of Angelica Gigas and Astragalus Membranaceus) in Men with Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    January 2025 in “ Investigative and Clinical Urology ”
    Ji Hun Lee, Dahye Yoon, Geum Duck Park, Kyung Seok Kim, Soo Ro Kim, Woo Cheol Shin, Seung Hwan Lee, Dae‐Young Lee
    Image
    Studysummary This study found that after 12 weeks of taking the trial product SHPro®, participants reported improvements in prostate symptom scores and erectile function, with confirmed safety.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    A 12-week randomized, double-blind, placebo-controlled clinical trial investigated the effects of SHPro® (a mixture of Angelica gigas and Astragalus membranaceus) on men with lower urinary tract symptoms. The study found that participants experienced improvements in total and incomplete emptying International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF), indicating subjective improvements. The safety of SHPro® was also confirmed.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results